Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • On the Market
  • Published:

Visualization of advanced human prostate cancer lesions in living mice by a targeted gene transfer vector and optical imaging

Abstract

Non-invasive imaging and transcriptional targeting can improve the safety of therapeutic approaches in cancer. Here we demonstrate the ability to identify metastases in a human-prostate cancer model, employing a prostate-specific adenovirus vector (AdPSE-BC-luc) and a charge-coupled device-imaging system. AdPSE-BC-luc, which expresses firefly luciferase from an enhanced prostate-specific antigen promoter, restricted expression in the liver but produced robust signals in prostate tumors. In fact, expression was higher in advanced, androgen-independent tumors than in androgen-dependent lesions. Repetitive imaging over a three-week period after AdPSE-BC-luc injection into tumor-bearing mice revealed that the virus could locate and illuminate metastases in the lung and spine. Systemic injection of low doses of AdPSE-BC-luc illuminated lung metastasis. These results demonstrate the potential use of a non-invasive imaging modality in therapeutic and diagnostic strategies to manage prostate cancer.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Adenoviral vector-mediated luciferase gene delivery and expression in the liver after systemic administration.
Figure 2: Kinetics of transgene expression in living mice after intratumoral injection.
Figure 3: Detailed histological analysis of spinal metastatic lesions.
Figure 4: Optical CCD detection and histological analysis of lung metastases.
Figure 5: Androgen-regulated gene expression in prostate cancer models.

References

  1. Nash, A.F. & Melezinek, I. The role of prostate specific antigen measurement in the detection and management of prostate cancer. Endocr. Relat. Cancer 7, 37–51 (2000).

    Article  CAS  Google Scholar 

  2. Rini, B.I. & Small, E.J. An update on prostate cancer. Curr. Opin. Oncol. 13, 204–211 (2001).

    Article  CAS  Google Scholar 

  3. Bloomfield, D.J. et al. Economic evaluation of chemotherapy with mitoxantrone plus prednisone for symptomatic hormone-resistant prostate cancer: based on a Canadian randomized trial with palliative end points. J. Clin. Oncol. 16, 2272–2279 (1998).

    Article  CAS  Google Scholar 

  4. Harrington, K.J., Spitzweg, C., Bateman, A.R., Morris, J.C. & Vile, R.G. Gene therapy for prostate cancer: Current status and future prospects. J. Urol. 166, 1220–1233 (2001).

    Article  CAS  Google Scholar 

  5. Wu, L. et al. Chimeric PSA enhancers exhibit augmented activity in prostate cancer gene therapy vectors. Gene Ther. 8, 1416–1426 (2001).

    Article  CAS  Google Scholar 

  6. Klein, K.A. et al. Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice. Nature Med. 3, 402–408 (1997).

    Article  CAS  Google Scholar 

  7. Craft, N. et al. Evidence for clonal outgrowth of androgen-independent prostate cancer cells from androgen-dependent tumors through a two-step process. Cancer Res. 59, 5030–5036 (1999).

    CAS  PubMed  Google Scholar 

  8. Rehemtulla, A. et al. Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging. Neoplasia 2, 491–495 (2000).

    Article  CAS  Google Scholar 

  9. Wu, J.C., Sundaresan, G., Iyer, M. & Gambhir, S.S. Noninvasive optical imaging of firefly luciferase reporter gene expression in skeletal muscles of living mice. Mol. Ther. 4, 297–306 (2001).

    Article  CAS  Google Scholar 

  10. Tao, N. et al. Sequestration of adenoviral vector by Kupffer cells leads to a nonlinear dose response of transduction in liver. Mol. Ther. 3, 28–35 (2001).

    Article  CAS  Google Scholar 

  11. Yang, Y. et al. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91, 4407–4411 (1994).

    Article  CAS  Google Scholar 

  12. Waller, A.S., Sharrard, R.M., Berthon, P. & Maitland, N.J. Androgen receptor localisation and turnover in human prostate epithelium treated with the antiandrogen, casodex. J. Mol. Endocrinol. 24, 339–351 (2000).

    Article  CAS  Google Scholar 

  13. Zhao, X.Y. et al. Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor. Nature Med. 6, 703–706 (2000).

    Article  CAS  Google Scholar 

  14. Linja, M.J. et al. Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer. Cancer Res. 61, 3550–3555 (2001).

    CAS  PubMed  Google Scholar 

  15. Craft, N., Shostak, Y., Carey, M. & Sawyers, C.L. A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase. Nature Med. 5, 280–285 (1999).

    Article  CAS  Google Scholar 

  16. Gregory, C.W. et al. A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy. Cancer Res. 61, 4315–4319 (2001).

    CAS  PubMed  Google Scholar 

  17. Zhang, L. et al. Molecular engineering of a two-step transcription amplification (TSTA) system for transgene delivery in prostate cancer. Mol. Ther. 5, 223–232 (2002).

    Article  CAS  Google Scholar 

  18. The Development of Human Gene Therapy. (ed. Freidmann, T.) (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1999).

  19. Yaghoubi, S.S. et al. Direct correlation between positron emission tomographic images of two reporter genes delivered by two distinct adenoviral vectors. Gene Ther. 8, 1072–1080 (2001).

    Article  CAS  Google Scholar 

  20. Leav, I. et al. Comparative studies of the estrogen receptors β and α and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma. Am. J. Pathol. 159, 79–92 (2001).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank A. Berk, U. Banerjee, H. Herschman, L. Rome, C. Sawyers, R. Reiter and J. Said for helpful advice and critical review of manuscript; Joseph Wu, Tina Yu, Joyce Yamashiro, Evelyn Kondo and Chris Tran for technical assistance; and W. Aft and D. Nusinow for assistance in the preparation of this manuscript. This work was initiated with seed funding from the California Cancer Research Coordinating Committee, the Carolan Foundation of UCLA and the California Cancer Research Program. L.W. is a member of the Jonsson Comprehensive Cancer Center and the recipient of a STOP Cancer research career development award. Cost of imaging was supported by NIH P50 CA86306 (S.S.G.), R0-1 CA82214 (S.S.G.), SAIRP R24 CA92865 (S.S.G.), Department of Energy Contract DE-FC03-87ER60615 (S.S.G.) and CaPCURE (S.S.G., M.C.).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lily Wu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Adams, J., Johnson, M., Sato, M. et al. Visualization of advanced human prostate cancer lesions in living mice by a targeted gene transfer vector and optical imaging. Nat Med 8, 891–896 (2002). https://doi.org/10.1038/nm743

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm743

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing